CMMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Chemomab Therapeutics Ltd.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026
$1.17−0.09 (-7.51%)
Close on Oct 19, 2026
- Market cap
- $749.09M
- P/E (TTM)
- 65.0
- Dividend yield
- –
Margins need revenue and profit figures
This company does not report the lines needed to calculate margins.
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| EPS, diluted | -53.8% | -47.0% | -16.4% | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | -51.4% | -69.5% | |
| Return on assets | – | -36.9% | -58.5% | |
| Current ratio | – | 9.00 | 9.08 | |
| Interest coverage | -663.1× | – | – | |
| Diluted shares | 19M | 137M | 510M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Chemomab Therapeutics generated $82.87M from operations and spent $313.00K on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$82.87M
Used
$313.00K
Capital expenditure$313.00K100%Dividends$00%Share buybacks$00%
DuPont needs revenue, assets and equity
This company does not report all three for consecutive years.
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
2of 6 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero-$9.00M
- Cash generatingOperating cash flow above zero-$11.13M
- Return on assets improvedROA up on the prior year-63.0% → -53.0%
- Earnings backed by cashOperating cash flow above net income-$11.13M vs -$9.00M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose4.98 → 9.08
- No dilutionShare count did not rise359M → 510M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose– → –